Evidence map›Paper›PMID 24090398›Full record

ArticleThe World Allergy Organization journal2013

A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics.

Giorgio Walter Canonica, Ignacio J Ansotegui, Ruby Pawankar, Peter Schmid-Grendelmeier, Marianne van Hage, Carlos E Baena-Cagnani, Giovanni Melioli, Carlos Nunes, Giovanni Passalacqua, Lanny Rosenwasser and 5 more

Open access · goldAbstract read
In one paragraph

Article in The World Allergy Organization journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
37.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 432 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. A Case Report of Anaphylaxis Induced by Mushroom (Journal of asthma and allergy · 2025
    Article
  9. A Chromosomal-Level Genome ofInternational journal of genomics · 2024
    Article
  10. Article
  11. Article
  12. Going over Fungal Allergy:Journal of fungi (Basel, Switzerland) · 2023
    Review
  13. Review
  14. Honey bee venom re-challenge during specific immunotherapy: prolonged cardio-pulmonary resuscitation allowed survival in a case of near fatal anaphylaxis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 9 countries.

Giorgio Walter CanonicaAllergy & Respiratory, DIMI, Department of Internal Medicine, University of Genoa, Largo Rosanna Benzi, Genoa, Italy. canonica@unige.it.
Ignacio J Ansotegui
Ruby Pawankar
Peter Schmid-Grendelmeier
Marianne van Hage
Carlos E Baena-Cagnani
Giovanni Melioli
Carlos Nunes
Giovanni Passalacqua
Lanny Rosenwasser
Hugh Sampson
Joaquin Sastre
Jean Bousquet
Torsten Zuberbier
WAO-ARIA-GA2LEN Task Force: Katrina Allen, Riccardo Asero, Barbara Bohle, Linda Cox, Frederic de Blay, Motohiro Ebisawa, Rene Maximiliano-Gomez, Sandra Gonzalez-Diaz, Tari Haahtela, Stephen Holgate, Thilo Jakob, Mark Larche, Paolo Maria Matricardi, John Oppenheimer, Lars K Poulsen, Harald E Renz, Nelson Rosario, Marc Rothenberg, Mario Sanchez-Borges, Enrico Scala, Rudolf Valenta
University of Genoa · ITAlgarve Biomedical Center · PTCharité - Universitätsmedizin Berlin · DEEuskadiko Parke Teknologikoa · ESHôpital Arnaud de Villeneuve · FRIcahn School of Medicine at Mount Sinai · USIstituto Giannina Gaslini · ITNippon Medical School · JPUniversidad Autónoma de Madrid · ESUniversidad Católica de Córdoba · ARUniversity Hospital of Zurich · CHUniversity of Missouri–Kansas City · US

Funding

Medical Research Council G0800766
6 · The paper itself

Abstract

Molecular-based allergy (MA) diagnostics is an approach used to map the allergen sensitization of a patient at a molecular level, using purified natural or recombinant allergenic molecules (allergen components) instead of allergen extracts. Since its introduction, MA diagnostics has increasingly entered routine care, with currently more than 130 allergenic molecules commercially available for in vitro specific IgE (sIgE) testing.MA diagnostics allows for an increased accuracy in allergy diagnosis and prognosis and plays an important role in three key aspects of allergy diagnosis: (1) resolving genuine versus cross-reactive sensitization in poly-sensitized patients, thereby improving the understanding of triggering allergens; (2) assessing, in selected cases, the risk of severe, systemic versus mild, local reactions in food allergy, thereby reducing unnecessary anxiety for the patient and the need for food challenge testing; and (3) identifying patients and triggering allergens for specific immunotherapy (SIT).Singleplex and multiplex measurement platforms are available for MA diagnostics. The Immuno-Solid phase Allergen Chip (ISAC) is the most comprehensive platform currently available, which involves a biochip technology to measure sIgE antibodies against more than one hundred allergenic molecules in a single assay. As the field of MA diagnostics advances, future work needs to focus on large-scale, population-based studies involving practical applications, elucidation and expansion of additional allergenic molecules, and support for appropriate test interpretation. With the rapidly expanding evidence-base for MA diagnosis, there is a need for allergists to keep abreast of the latest information. The aim of this consensus document is to provide a practical guide for the indications, determination, and interpretation of MA diagnostics for clinicians trained in allergology.

Identifiers

PMID24090398
PMCPMC3874689
OpenAlexW2125134101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.